Document Type
Article
Publication Date
2013
Abstract
An imminent US Supreme Court ruling should resolve one of the thorniest legal issues facing pharmaceutical companies today.
Recommended Citation
Nature Biotechnology, Vol. 31, p. 316, 2013
Included in
Antitrust and Trade Regulation Commons, Intellectual Property Law Commons, Medical Jurisprudence Commons, Science and Technology Law Commons
